Chronic inducible urticaria (CIU) is a a significant dermatological condition characterized by persistent hives triggered by specific stimuli. The global market for CIU treatments is projected to witness significant expansion over the upcoming few years, driven by contributing elements such as rising prevalence of CIU, enhanced diagnostic capabilit